Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05359211
Title NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
Recruitment Not yet recruiting
Gender
Phase Phase I
Variant Requirements No
Sponsors Fred Hutchinson Cancer Center
Indications

B-cell lymphoma

primary mediastinal B-cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

Therapies

NKTR-255

Cyclophosphamide + Fludarabine + Lisocabtagene maraleucel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.